Kevin Forrest - Net Worth and Insider Trading

Kevin Forrest Net Worth

The estimated net worth of Kevin Forrest is at least $216,935 dollars as of 2025-07-18. Kevin Forrest is the Chief Scientific Officer of Cidara Therapeutics Inc and owns about 3,618 shares of Cidara Therapeutics Inc (CDTX) stock worth over $216,935. Details can be seen in Kevin Forrest's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Forrest has not made any transactions after 2017-03-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Kevin Forrest

To

Kevin Forrest Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Forrest owns 1 companies in total, including Cidara Therapeutics Inc (CDTX) .

Click here to see the complete history of Kevin Forrest’s form 4 insider trades.

Insider Ownership Summary of Kevin Forrest

Ticker Company Transaction Date Type of Owner
CDTX Cidara Therapeutics Inc 2017-03-31 COO & CFO

Kevin Forrest Latest Holdings Summary

Kevin Forrest currently owns a total of 1 stock. Kevin Forrest owns 3,618 shares of Cidara Therapeutics Inc (CDTX) as of March 31, 2017, with a value of $216,935.

Latest Holdings of Kevin Forrest

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDTX Cidara Therapeutics Inc 2017-03-31 3,618 59.96 216,935

Holding Weightings of Kevin Forrest


Kevin Forrest Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Forrest has made a total of 0 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 625 shares on March 31, 2017, which cost Kevin Forrest around $96,875.

Insider Trading History of Kevin Forrest

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Forrest Trading Performance

GuruFocus tracks the stock performance after each of Kevin Forrest's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Forrest is -10.07%. GuruFocus also compares Kevin Forrest's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Forrest within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin Forrest's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin Forrest

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.05 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.56 LIMIT LIMIT LIMIT LIMIT LIMIT

Kevin Forrest Ownership Network

Ownership Network List of Kevin Forrest

No Data

Ownership Network Relation of Kevin Forrest

Insider Network Chart


Kevin Forrest Owned Company Details

What does Cidara Therapeutics Inc do?

Who are the key executives at Cidara Therapeutics Inc?

Kevin Forrest is the COO & CFO of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , CHIEF LEGAL OFFICER Shane Ward , and Chief Medical Officer Taylor Sandison .

Cidara Therapeutics Inc (CDTX) Insider Trades Summary

Over the past 18 months, Kevin Forrest made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 23,711 shares made by Leslie Tari , a net sale of 22,137 shares made by Shane Ward , and a net sale of 21,586 shares made by Taylor Sandison .

In summary, during the past 3 months, insiders sold 0 shares of Cidara Therapeutics Inc (CDTX) in total and bought 2,276,047 shares, with a net purchase of 2,276,047 shares. During the past 18 months, 9,325 shares of Cidara Therapeutics Inc (CDTX) were sold and 2,284,047 shares were bought by its insiders, resulting in a net purchase of 2,274,722 shares.

Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cidara Therapeutics Inc Insider Transactions

No Available Data

Kevin Forrest Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Forrest. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Kevin Forrest's mailing address is: San Diego Ca 92121.